Prosecution Insights
Last updated: October 27, 2026

William Justin Youngblood, USPTO Patent Examiner

Listed by the USPTO as YOUNGBLOOD, WILLIAM JUSTIN

Tech Center 4100 • Art Units: 1629 1645 4100

This examiner grants 60% of resolved cases

Analysis

YOUNGBLOOD, WILLIAM JUSTIN is assigned to Tech Center 4100 and Art Unit 1629. The profile includes 80 resolved cases and shows a 60.0% allowance rate. Interviews are associated with a 41.6% lift in allowance outcomes. The median time to allowance is 1213 days.

The listed companies are The Regents of the University of California, University of Florida Research Foundation Inc., and Syngenta AG. The listed firms are SUGHRUE MION, PLLC, VIKSNINS HARRIS PADYS MALEN LLP, and BakerHostetler. The limited record counsels against treating the figures as a complete forecast, but the interview measure supports well-prepared examiner discussions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

60.0%
Allow Rate
At TC average
116
Total Applications
+41.6%
Interview Lift
1213
Avg Prosecution Days
Based on 80 resolved cases, 2023–2026

Rejection Statute Breakdown

3.6%
§101 Eligibility
24.8%
§102 Novelty
27.0%
§103 Obviousness
27.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18867302 PESTICIDAL COMPOSITIONS Non-Final OA SYNGENTA CROP PROTECTION AG
18868132 METHODS FOR COBINAMIDE SYNTHESIS Non-Final OA The Regents of the University of California
18706266 CANNABIGEROL FOR TREATMENT OF SEIZURES AND EPILEPSY Non-Final OA The Regents of the University of California
18728431 COMPOUND COMPRISING RALTITREXED OR 5-MTHF LINKED TO A THERAPEUTIC AGENT, COMPOSITION, AND METHOD OF USE Non-Final OA PURDUE RESEARCH FOUNDATION
18710002 FLUCONAZOLE-COX INHIBITOR HYBRIDS: A DUAL-ACTING CLASS OF ANTIFUNGAL AZOLES Non-Final OA Ramot at Tel-Aviv University Ltd.
18253229 Methods of Using 4-Amino-N-[4-(Methoxymethyl)Phenyl]-7-(1-Methylcyclopropyl)-6-(3-Morpholinoprop-1-YN-1-YL)-7H-Pyrrolo[2,3-D]Pyrimidine-5-Carboxamide for the Treatment of Tumors Final Rejection Taiho Pharmaceutical Co., Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner William Justin Youngblood's allowance rate?

60.0% of resolved applications examined by William Justin Youngblood were allowed (80 resolved cases), compared with 42.3% across Art Unit 1629 over the last five years.

Does an interview help with examiner William Justin Youngblood?

This examiner's interview lift is +41.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner William Justin Youngblood take to allow a patent?

Applications allowed by William Justin Youngblood took 1,213 days on average from filing to allowance.

Which art unit does examiner William Justin Youngblood work in?

William Justin Youngblood examines applications in Art Unit 1629 in Tech Center 4100.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month